Graham Capital Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4M | Buy |
110,088
+30,612
| +39% | +$1.11M | 0.06% | 152 |
|
|
2025
Q1 | $2.88M | Buy |
79,476
+20,347
| +34% | +$737K | 0.05% | 210 |
|
|
2024
Q4 | $2.49M | Buy |
59,129
+16,128
| +38% | +$679K | 0.04% | 224 |
|
|
2024
Q3 | $2.39M | Sell |
43,001
-12,572
| -23% | -$698K | 0.04% | 209 |
|
|
2024
Q2 | $2.28M | Buy |
55,573
+11,538
| +26% | +$474K | 0.05% | 195 |
|
|
2024
Q1 | $2.06M | Buy |
44,035
+30,175
| +218% | +$1.41M | 0.04% | 227 |
|
|
2023
Q4 | $663K | Buy |
+13,860
| New | +$663K | 0.01% | 477 |
|
|
2022
Q4 | – | Sell |
-5,936
| Closed | -$245K | – | 1285 |
|
|
2022
Q3 | $245K | Buy |
+5,936
| New | +$245K | 0.01% | 949 |
|